Barriers and Opportunities for Use of Patient Registries in Medicines Regulation

Clin Pharmacol Ther. 2019 Jul;106(1):39-42. doi: 10.1002/cpt.1414. Epub 2019 Apr 10.

Authors

Carla Alonso Olmo¹, Patricia McGettigan^{1

2}, Xavier Kurz¹

Affiliations

¹ Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands.
² William Harvey Research Institute, Queen Mary University of London, London, UK.

No abstract available

MeSH terms

Big Data
Data Accuracy
Decision Making*
Drug and Narcotic Control / legislation & jurisprudence
Drug and Narcotic Control / organization & administration*
Drug and Narcotic Control / statistics & numerical data
Europe
Humans
Information Systems
Observational Studies as Topic
Product Surveillance, Postmarketing / methods*
Registries*